Circuits controlling energy balance and mood: Inherently intertwined or just complicated intersections?

Cell Metabolism

Volumn 19, Issue 6, 2014, Pages 902-909

  Liu, Chen ^a   Lee, Syann ^a   Elmquist, Joel K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; PSYCHOTROPIC AGENT; ANOREXIGENIC AGENT; NEUROLEPTIC AGENT;

BARIATRIC SURGERY; BODY WEIGHT; BRAIN REGION; CENTRAL NERVOUS SYSTEM FUNCTION; DRUG MECHANISM; ENERGY BALANCE; FOOD INTAKE; HUMAN; MOOD; OBESITY; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; WEIGHT REDUCTION; ADVERSE EFFECTS; AFFECT; CALORIC INTAKE; CHEMICALLY INDUCED; DRUG EFFECTS; EATING; ENERGY METABOLISM; LOW CALORY DIET; METABOLISM; MOOD DISORDER; PHYSIOLOGY; PSYCHOLOGY; WEIGHT GAIN; WEIGHT LOSS PROGRAM; BRAIN DEPTH STIMULATION; HOMEOSTASIS; OUTCOME ASSESSMENT;

AFFECT; ANTIPSYCHOTIC AGENTS; APPETITE DEPRESSANTS; APPETITE REGULATION; BARIATRIC SURGERY; DIET, REDUCING; EATING; ENERGY INTAKE; ENERGY METABOLISM; HUMANS; MOOD DISORDERS; OBESITY; WEIGHT GAIN; WEIGHT REDUCTION PROGRAMS;

EID: 84902243854     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2014.02.008     Document Type: Review

References (103)

1. M.C. Acosta, J. Manubay, and F.R. Levin Pediatric obesity: parallels with addiction and treatment recommendations Harv. Rev. Psychiatry 16 2008 80 96
2. T.D. Adams, R.E. Gress, S.C. Smith, R.C. Halverson, S.C. Simper, W.D. Rosamond, M.J. Lamonte, A.M. Stroup, and S.C. Hunt Long-term mortality after gastric bypass surgery N. Engl. J. Med. 357 2007 753 761
3. D.B. Allison, and D.E. Casey Antipsychotic-induced weight gain: a review of the literature J. Clin. Psychiatry 62 Suppl 7 2001 22 31
4. N.B. Almandil, and I.C. Wong Review on the current use of antipsychotic drugs in children and adolescents Arch. Dis. Child. Educ. Pract. Ed. 96 2011 192 196
5. Y. Aponte, D. Atasoy, and S.M. Sternson AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training Nat. Neurosci. 14 2011 351 355
6. C.H. Ashton, and P.B. Moore Endocannabinoid system dysfunction in mood and related disorders Acta Psychiatr. Scand. 124 2011 250 261
7. J. Bachevalier, C.J. Machado, and A. Kazama Behavioral outcomes of late-onset or early-onset orbital frontal cortex (areas 11/13) lesions in rhesus monkeys Ann. N Y Acad. Sci. 1239 2011 71 86
8. E.D. Berglund, C. Liu, J.W. Sohn, T. Liu, M.H. Kim, C.E. Lee, C.R. Vianna, K.W. Williams, Y. Xu, and J.K. Elmquist Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis J. Clin. Invest. 123 2013 5061 5070
9. R.N. Bergman, and M. Ader Atypical antipsychotics and glucose homeostasis J. Clin. Psychiatry 66 2005 504 514
10. H.R. Berthoud, A.C. Shin, and H. Zheng Obesity surgery and gut-brain communication Physiol. Behav. 105 2011 106 119
11. J.J. Bonfiglio, C. Inda, D. Refojo, F. Holsboer, E. Arzt, and S. Silberstein The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: molecular and cellular mechanisms involved Neuroendocrinology 94 2011 12 20
12. F.P. Bymaster, D.L. Nelson, N.W. DeLapp, J.F. Falcone, K. Eckols, L.L. Truex, M.M. Foreman, V.L. Lucaites, and D.O. Calligaro Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro Schizophr. Res. 37 1999 107 122
13. J.C. Chuang, and J.M. Zigman Ghrelin's Roles in Stress, Mood, and Anxiety Regulation Int. J. Pept. 2010 2010 2010
14. H.M. Connolly, J.L. Crary, M.D. McGoon, D.D. Hensrud, B.S. Edwards, W.D. Edwards, and H.V. Schaff Valvular heart disease associated with fenfluramine-phentermine N. Engl. J. Med. 337 1997 581 588
15. D. Cota, G. Marsicano, M. Tschöp, Y. Grübler, C. Flachskamm, M. Schubert, D. Auer, A. Yassouridis, C. Thöne-Reineke, and S. Ortmann et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis J. Clin. Invest. 112 2003 423 431
16. D. Cota, M.A. Steiner, G. Marsicano, C. Cervino, J.P. Herman, Y. Grübler, J. Stalla, R. Pasquali, B. Lutz, G.K. Stalla, and U. Pagotto Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function Endocrinology 148 2007 1574 1581
17. J.P. Després, A. Golay, L. Sjöström Rimonabant in Obesity-Lipids Study Group Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia N. Engl. J. Med. 353 2005 2121 2134
18. S. Di, R. Malcher-Lopes, K.C. Halmos, and J.G. Tasker Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism J. Neurosci. 23 2003 4850 4857
19. M.O. Dietrich, J. Bober, J.G. Ferreira, L.A. Tellez, Y.S. Mineur, D.O. Souza, X.B. Gao, M.R. Picciotto, I. Araújo, Z.W. Liu, and T.L. Horvath AgRP neurons regulate development of dopamine neuronal plasticity and nonfood-associated behaviors Nat. Neurosci. 15 2012 1108 1110
20. W.C. Drevets, C. Gautier, J.C. Price, D.J. Kupfer, P.E. Kinahan, A.A. Grace, J.L. Price, and C.A. Mathis Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria Biol. Psychiatry 49 2001 81 96
21. J.P. Dunn, R.L. Cowan, N.D. Volkow, I.D. Feurer, R. Li, D.B. Williams, R.M. Kessler, and N.N. Abumrad Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings Brain Res. 1350 2010 123 130
22. J.K. Elmquist, R. Coppari, N. Balthasar, M. Ichinose, and B.B. Lowell Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis J. Comp. Neurol. 493 2005 63 71
23. M.S. Faith, M. Butryn, T.A. Wadden, A. Fabricatore, A.M. Nguyen, and S.B. Heymsfield Evidence for prospective associations among depression and obesity in population-based studies Obes. Rev. 12 2011 e438 e453
24. B. Finan, B. Yang, N. Ottaway, K. Stemmer, T.D. Müller, C.X. Yi, K. Habegger, S.C. Schriever, C. García-Cáceres, and D.G. Kabra et al. Targeted estrogen delivery reverses the metabolic syndrome Nat. Med. 18 2012 1847 1856
25. G. Frühbeck, A. Diez-Caballero, M.J. Gil, I. Montero, J. Gómez-Ambrosi, J. Salvador, and J.A. Cienfuegos The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus Obes. Surg. 14 2004 606 612
26. S. Fulton, P. Pissios, R.P. Manchon, L. Stiles, L. Frank, E.N. Pothos, E. Maratos-Flier, and J.S. Flier Leptin regulation of the mesoaccumbens dopamine pathway Neuron 51 2006 811 822
27. B.M. Geiger, G.G. Behr, L.E. Frank, A.D. Caldera-Siu, M.C. Beinfeld, E.G. Kokkotou, and E.N. Pothos Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats FASEB J. 22 2008 2740 2746
28. R. Gómez, M. Navarro, B. Ferrer, J.M. Trigo, A. Bilbao, I. Del Arco, A. Cippitelli, F. Nava, D. Piomelli, and F. Rodríguez de Fonseca A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding J. Neurosci. 22 2002 9612 9617
29. H.J. Grill, and M.R. Hayes Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance Cell Metab. 16 2012 296 309
30. W.W. Hamburger Emotional aspects of obesity Med. Clin. North Am. 35 1951 483 499
31. K.M. Hegadoren, T. O'Donnell, R. Lanius, N.J. Coupland, and N. Lacaze-Masmonteil The role of beta-endorphin in the pathophysiology of major depression Neuropeptides 43 2009 341 353
32. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Cannabinoid receptor localization in brain Proc. Natl. Acad. Sci. USA 87 1990 1932 1936
33. J.D. Hommel, R. Trinko, R.M. Sears, D. Georgescu, Z.W. Liu, X.B. Gao, J.J. Thurmon, M. Marinelli, and R.J. DiLeone Leptin receptor signaling in midbrain dopamine neurons regulates feeding Neuron 51 2006 801 810
34. A.C. Howlett The cannabinoid receptors Prostaglandins Other Lipid Mediat. 68-69 2002 619 631
35. C. Hryhorczuk, S. Sharma, and S.E. Fulton Metabolic disturbances connecting obesity and depression Front Neurosci 7 2013 177
36. V. Ionut, M. Burch, A. Youdim, and R.N. Bergman Gastrointestinal hormones and bariatric surgery-induced weight loss Obesity (Silver Spring) 21 2013 1093 1103
37. Y.H. Jo, Y.J. Chen, S.C. Chua Jr., D.A. Talmage, and L.W. Role Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit Neuron 48 2005 1055 1066
38. P.M. Johnson, and P.J. Kenny Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats Nat. Neurosci. 13 2010 635 641
39. P.J. Kenny Reward mechanisms in obesity: new insights and future directions Neuron 69 2011 664 679
40. M. Kluge, A. Schuld, H. Himmerich, M. Dalal, A. Schacht, P.M. Wehmeier, D. Hinze-Selch, T. Kraus, R.W. Dittmann, and T. Pollmächer Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study J. Clin. Psychopharmacol. 27 2007 662 666
41. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660
42. B. Kola, I. Farkas, M. Christ-Crain, G. Wittmann, F. Lolli, F. Amin, J. Harvey-White, Z. Liposits, G. Kunos, and A.B. Grossman et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system PLoS ONE 3 2008 e1797
43. M.J. Krashes, S. Koda, C. Ye, S.C. Rogan, A.C. Adams, D.S. Cusher, E. Maratos-Flier, B.L. Roth, and B.B. Lowell Rapid, reversible activation of AgRP neurons drives feeding behavior in mice J. Clin. Invest. 121 2011 1424 1428
44. T. Kraus, M. Haack, A. Schuld, D. Hinze-Selch, and T. Pollmächer Low leptin levels but normal body mass indices in patients with depression or schizophrenia Neuroendocrinology 73 2001 243 247
45. W.K. Kroeze, S.J. Hufeisen, B.A. Popadak, S.M. Renock, S. Steinberg, P. Ernsberger, K. Jayathilake, H.Y. Meltzer, and B.L. Roth H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs Neuropsychopharmacology 28 2003 519 526
46. B. Le Foll, D.A. Gorelick, and S.R. Goldberg The future of endocannabinoid-oriented clinical research after CB1 antagonists Psychopharmacology (Berl.) 205 2009 171 174
47. X.Y. Lu The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr. Opin. Pharmacol. 7 2007 648 652
48. X.Y. Lu, C.S. Kim, A. Frazer, and W. Zhang Leptin: a potential novel antidepressant Proc. Natl. Acad. Sci. USA 103 2006 1593 1598
49. M. Lutter, I. Sakata, S. Osborne-Lawrence, S.A. Rovinsky, J.G. Anderson, S. Jung, S. Birnbaum, M. Yanagisawa, J.K. Elmquist, E.J. Nestler, and J.M. Zigman The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress Nat. Neurosci. 11 2008 752 753
50. H.K. Manji, W.C. Drevets, and D.S. Charney The cellular neurobiology of depression Nat. Med. 7 2001 541 547
51. T. Masaki, S. Chiba, T. Yasuda, H. Noguchi, T. Kakuma, T. Watanabe, T. Sakata, and H. Yoshimatsu Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity Diabetes 53 2004 2250 2260
52. I. Matias, S. Petrosino, A. Racioppi, R. Capasso, A.A. Izzo, and V. Di Marzo Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets Mol. Cell. Endocrinol. 286 Suppl 1 2008 S66 S78
53. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
54. A. McCloughen, and K. Foster Weight gain associated with taking psychotropic medication: an integrative review Int. J. Ment. Health Nurs. 20 2011 202 222
55. G. Mingrone, S. Panunzi, A. De Gaetano, C. Guidone, A. Iaconelli, L. Leccesi, G. Nanni, A. Pomp, M. Castagneto, G. Ghirlanda, and F. Rubino Bariatric surgery versus conventional medical therapy for type 2 diabetes N. Engl. J. Med. 366 2012 1577 1585
56. I. Modai, A. Valevski, S. Dror, and A. Weizman Serum cholesterol levels and suicidal tendencies in psychiatric inpatients J. Clin. Psychiatry 55 1994 252 254
57. T.H. Moran Gut peptides in the control of food intake Int J Obes (Lond) 33 Suppl 1 2009 S7 S10
58. T.H. Moran, S. Aja, and E.E. Ladenheim Leptin modulation of peripheral controls of meal size Physiol. Behav. 89 2006 511 516
59. R.M. Murray, P.D. Morrison, C. Henquet, and M. Di Forti Cannabis, the mind and society: the hash realities Nat. Rev. Neurosci. 8 2007 885 895
60. A. Must, J. Spadano, E.H. Coakley, A.E. Field, G. Colditz, and W.H. Dietz The disease burden associated with overweight and obesity JAMA 282 1999 1523 1529
61. M. Narita, Y. Nagumo, S. Hashimoto, M. Narita, J. Khotib, M. Miyatake, T. Sakurai, M. Yanagisawa, T. Nakamachi, S. Shioda, and T. Suzuki Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine J. Neurosci. 26 2006 398 405
62. M. Navarro, E. Hernández, R.M. Muñoz, I. del Arco, M.A. Villanúa, M.R. Carrera, and F. Rodríguez de Fonseca Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat Neuroreport 8 1997 491 496
63. E.J. Nestler, and W.A. Carlezon Jr. The mesolimbic dopamine reward circuit in depression Biol. Psychiatry 59 2006 1151 1159
64. K. Nonogaki, A.M. Strack, M.F. Dallman, and L.H. Tecott Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene Nat. Med. 4 1998 1152 1156
65. R. Norgren, A. Hajnal, and S.S. Mungarndee Gustatory reward and the nucleus accumbens Physiol. Behav. 89 2006 531 535
66. D. Osei-Hyiaman, M. DePetrillo, P. Pacher, J. Liu, S. Radaeva, S. Bátkai, J. Harvey-White, K. Mackie, L. Offertáler, L. Wang, and G. Kunos Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity J. Clin. Invest. 115 2005 1298 1305
67. M.L. Pelchat, A. Johnson, R. Chan, J. Valdez, and J.D. Ragland Images of desire: food-craving activation during fMRI Neuroimage 23 2004 1486 1493
68. C. Peterhänsel, D. Petroff, G. Klinitzke, A. Kersting, and B. Wagner Risk of completed suicide after bariatric surgery: a systematic review Obes. Rev. 14 2013 369 382
69. N.M. Petry, D. Barry, R.H. Pietrzak, and J.A. Wagner Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions Psychosom. Med. 70 2008 288 297
70. F.X. Pi-Sunyer, L.J. Aronne, H.M. Heshmati, J. Devin, J. Rosenstock RIO-North America Study Group Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial JAMA 295 2006 761 775
71. L. Plum, M. Schubert, and J.C. Brüning The role of insulin receptor signaling in the brain Trends Endocrinol. Metab. 16 2005 59 65
72. W.J. Pories, M.S. Swanson, K.G. MacDonald, S.B. Long, P.G. Morris, B.M. Brown, H.A. Barakat, R.A. deRamon, G. Israel, and J.M. Dolezal et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann. Surg. 222 1995 339 350 discussion 350-352
73. G.P. Reynolds, Z.J. Zhang, and X.B. Zhang Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism Lancet 359 2002 2086 2087
74. N.E. Rowland, and J. Carlton Neurobiology of an anorectic drug: fenfluramine Prog. Neurobiol. 27 1986 13 62
75. M.A. Ruby, D.K. Nomura, C.S. Hudak, A. Barber, J.E. Casida, and R.M. Krauss Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes PLoS ONE 6 2011 e26415
76. C.B. Saper The central autonomic nervous system: conscious visceral perception and autonomic pattern generation Annu. Rev. Neurosci. 25 2002 433 469
77. P.R. Schauer, S.R. Kashyap, K. Wolski, S.A. Brethauer, J.P. Kirwan, C.E. Pothier, S. Thomas, B. Abood, S.E. Nissen, and D.L. Bhatt Bariatric surgery versus intensive medical therapy in obese patients with diabetes N. Engl. J. Med. 366 2012 1567 1576
78. M.M. Scott, J.L. Lachey, S.M. Sternson, C.E. Lee, C.F. Elias, J.M. Friedman, and J.K. Elmquist Leptin targets in the mouse brain J. Comp. Neurol. 514 2009 518 532
79. J. Simiand, M. Keane, P.E. Keane, and P. Soubrié SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset Behav. Pharmacol. 9 1998 179 181
80. W.K. Simmons, A. Martin, and L.W. Barsalou Pictures of appetizing foods activate gustatory cortices for taste and reward Cereb. Cortex 15 2005 1602 1608
81. D.M. Small, M. Jones-Gotman, and A. Dagher Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers Neuroimage 19 2003 1709 1715
82. M.A. Steiner, K. Wanisch, K. Monory, G. Marsicano, E. Borroni, H. Bächli, F. Holsboer, B. Lutz, and C.T. Wotjak Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice Pharmacogenomics J. 8 2008 196 208
83. E. Stellar The physiology of motivation Psychol. Rev. 61 1954 5 22
84. E. Stice, S. Spoor, C. Bohon, and D.M. Small Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele Science 322 2008 449 452
85. A.J. Stunkard, and J. Rush Dieting and depression reexamined. A critical review of reports of untoward responses during weight reduction for obesity Ann. Intern. Med. 81 1974 526 533
86. M.S. Szczypka, K. Kwok, M.D. Brot, B.T. Marck, A.M. Matsumoto, B.A. Donahue, and R.D. Palmiter Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice Neuron 30 2001 819 828
87. Z. Taslimi, A. Haghparast, M. Hassanpour-Ezatti, and M.S. Safari Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area Behav. Brain Res. 217 2011 41 46
88. L.H. Tecott, L.M. Sun, S.F. Akana, A.M. Strack, D.H. Lowenstein, M.F. Dallman, and D. Julius Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors Nature 374 1995 542 546
89. K.L. Teff, and S.F. Kim Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism Physiol. Behav. 104 2011 590 598
90. L.A. Tellez, S. Medina, W. Han, J.G. Ferreira, P. Licona-Limón, X. Ren, T.T. Lam, G.J. Schwartz, and I.E. de Araujo A gut lipid messenger links excess dietary fat to dopamine deficiency Science 341 2013 800 802
91. L.A. Templeman, G.P. Reynolds, B. Arranz, and L. San Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis Pharmacogenet. Genomics 15 2005 195 200
92. H.A. Tindle, B. Omalu, A. Courcoulas, M. Marcus, J. Hammers, and L.H. Kuller Risk of suicide after long-term follow-up from bariatric surgery Am. J. Med. 123 2010 1036 1042
93. N. Torres, S. Chabardes, B. Piallat, A. Devergnas, and A.L. Benabid Body fat and body weight reduction following hypothalamic deep brain stimulation in monkeys: an intraventricular approach Int J Obes (Lond) 36 2012 1537 1544
94. L.F. Van Gaal, A.M. Rissanen, A.J. Scheen, O. Ziegler, S. Rössner RIO-Europe Study Group Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study Lancet 365 2005 1389 1397
95. N.D. Volkow, J.S. Fowler, G.J. Wang, J.M. Swanson, and F. Telang Dopamine in drug abuse and addiction: results of imaging studies and treatment implications Arch. Neurol. 64 2007 1575 1579
96. G.J. Wang, N.D. Volkow, F. Telang, M. Jayne, J. Ma, M. Rao, W. Zhu, C.T. Wong, N.R. Pappas, A. Geliebter, and J.S. Fowler Exposure to appetitive food stimuli markedly activates the human brain Neuroimage 21 2004 1790 1797
97. G.J. Wang, N.D. Volkow, F. Telang, M. Jayne, Y. Ma, K. Pradhan, W. Zhu, C.T. Wong, P.K. Thanos, and A. Geliebter et al. Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation Proc. Natl. Acad. Sci. USA 106 2009 1249 1254
98. A. Wendling, and A. Wudyka Narcotic addiction following gastric bypass surgery - a case study Obes. Surg. 21 2011 680 683
99. D.M. Whiting, N.D. Tomycz, J. Bailes, L. de Jonge, V. Lecoultre, B. Wilent, D. Alcindor, E.R. Prostko, B.C. Cheng, and C. Angle et al. Lateral hypothalamic area deep brain stimulation for refractory obesity: a pilot study with preliminary data on safety, body weight, and energy metabolism J. Neurosurg. 119 2013 56 63
100. Q. Wu, M.S. Clark, and R.D. Palmiter Deciphering a neuronal circuit that mediates appetite Nature 483 2012 594 597
101. Y. Xu, J.E. Jones, D. Kohno, K.W. Williams, C.E. Lee, M.J. Choi, J.G. Anderson, L.K. Heisler, J.M. Zigman, B.B. Lowell, and J.K. Elmquist 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis Neuron 60 2008 582 589
102. C. Zhan, J. Zhou, Q. Feng, J.E. Zhang, S. Lin, J. Bao, P. Wu, and M. Luo Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively J. Neurosci. 33 2013 3624 3632
103. J.M. Zigman, J.E. Jones, C.E. Lee, C.B. Saper, and J.K. Elmquist Expression of ghrelin receptor mRNA in the rat and the mouse brain J. Comp. Neurol. 494 2006 528 548